Preventive effect of flavangenol on ischemia/reperfusion-induced acute renal failure in rats

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 9, 2005, Pages 1655-1657

  Ohkita, Mamoru ^a   Nakajima, Atsushi ^a   Ueda, Kyoko ^a   Takaoka, Masanori ^a   Kiso, Yoshinobu ^b   Matsumura, Yasuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b SUNTORY LTD   (Japan)

Author keywords

Acute renal failure; Flavangenol; Ischemia; Reperfusion

Indexed keywords

CREATININE; FLAVAN DERIVATIVE; FLAVANGENOL; SODIUM ION; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE SEVERITY; DRUG EFFECT; HISTOPATHOLOGY; KIDNEY ARTERY STENOSIS; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE NECROSIS; MALE; MICTURITION; NEPHRECTOMY; NONHUMAN; PARAMETER; RAT; REACTION TIME; REPERFUSION INJURY; SODIUM EXCRETION; STATISTICAL SIGNIFICANCE; UREA NITROGEN BLOOD LEVEL; URINE OSMOLALITY;

ANIMALS; BIFLAVONOIDS; KIDNEY; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; MALE; NECROSIS; PROANTHOCYANIDINS; RATS; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; REPERFUSION INJURY; WATER-ELECTROLYTE BALANCE;

EID: 24944482455     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.1655     Document Type: Article

References (18)

1. Rohdewald P., Int. J. Clin. Pharmacol. Ther., 40, 158-168 (2002).
2. Edelstein C. L., Ling H., Schrier R. W., Kidney Int., 51, 1341-1351 (1997).
3. Padanilam B. J., Am. J. Physiol. Renal. Physiol., 284, F608-F627 (2003).
4. Fujii T., Takaoka M., Tsuruoka N., Kiso Y., Tanaka T., Matsumura Y., Biol. Pharm. Bull., 28, 361-363 (2005).
5. Lieberthal W., Levine J. S., Am. J. Physiol., 271, F477-F488 (1996).
6. Fujii T., Takaoka M., Muraoka T., Kurata H., Tsuruoka N., Ono H., Kiso Y., Tanaka T., Matsumura Y., Eur. J. Pharmacol., 474, 261-267 (2003).
7. Takaoka M., Ohkita M., Kobayashi T., Yuba M., Matusmura Y., Clin. Exp. Pharmacol. Physiol., 29, 189-194 (2002).
8. Doi K., Suzuki Y., Nakao A., Fujita T., Noiri E., Kidney Int., 65, 1714-1723 (2004).
9. Kasuno K., Nakamura H., Ono T., Muso E., Yodoi J., Kidney Int., 64, 1273-1282 (2003).
10. Maffei Facino R., Carini M., Aldini G., Berti F., Rossoni G., Bombardelli E., Morazzoni P., Planta Med., 62, 495-502 (1996).
11. Maffei Facino R., Carini M., Aldini G., Berti F., Rossoni G., Bombardelli E., Morazzoni P., Life Sci., 64, 627-642 (1999).
12. Lipton P., Physiol. Rev., 79, 1431-1568 (1999).
13. Devarajan P., Mishra J., Supavekin S., Patterson L.T., Steven Potter S., Mol. Genet. Metab., 80, 365-376 (2003).
14. Richmond A., Nat. Rev. Immunol., 2, 664-674 (2002).
15. Takaoka M., Matsumura Y., Recent Res. Devel. Life Sci., 1, 203-220 (2003).
16. Azuma H., Tomita N., Kaneda Y., Koike H., Ogihara T., Katsuoka Y., Morishita R., Gene Ther., 10, 415-425 (2003).
17. Peng Q., Wei Z., Lau B. H., Cell Mol. Life Sci., 57, 834-841 (2000).
18. Cho K. J., Yun C. H., Yoon D. Y., Cho Y. S., Rimbach G., Packer L., Chung A. S., Toxicol. Appl. Pharmacol., 168, 64-71 (2000).